Use of an Interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
Details for Australian Patent Application No. 2003246583 (hide)
International Classifications
Event Publications
2 October 2003 Complete Application Filed
Priority application(s): 60/392,650 27.06.02 US
4 March 2004 Application Open to Public Inspection
Published as AU-B-2003246583
14 February 2008 Application Accepted
Published as AU-B-2003246583
19 June 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003246584-A DEVICE FOR EXCHAGING DATA BETWEEN MOVING VEHICLES
2003246582-NOVEL MEDICAMENT COMBINATIONS BASED ON SODIUM CHANNEL BLOCKERS AND MAGNESIUM SALTS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser